Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Oberic

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Emerging Infectious Diseases|July 22, 2015
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic MalignanciesSuzanne Tavitian, Jean-Marie Peron, Françoise Huguet, et al.
American Journal of Hematology|July 22, 2014
Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomasMarielle Perry, Antoine Delarche, David Ribes, et al.
American Journal of Hematology|November 24, 2017
Bendamustine plus rituximab for indolent B-cell lymphoma of renal significanceDavid Ribes, Hélène E L Hachem, Lucie Oberic, et al.
Annals of Hematology|November 27, 2025
Length of hospital stay and outcome in primary central nervous system lymphoma: a French retrospective multicentric studyRaphaël Maguet, Martin Eloit, Olivier Chinot, et al.
Journal of Clinical Medicine|February 15, 2022
Spectrum of Kidney Disorders Associated with T-Cell ImmunoclonesAlexis Piedrafita, François Vergez, Julie Belliere, et al.
Blood Cancer Journal|November 3, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trialsValentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, et al.
British Journal of Haematology|April 4, 2018
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA studyBenedicte Deau, Sandy Amorim, Aurore Perrot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 12, 2024
MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of Self-supervised Deep Learning ModelsCharlotte Syrykh, Valentina Di Proietto, Eliott Brion, et al.
Oncoimmunology|December 20, 2016
Impaired functional responses in follicular lymphoma CD8<sup>+</sup>TIM-3<sup>+</sup> T lymphocytes following TCR engagementPauline Gravelle, Catherine Do, Camille Franchet, et al.
Blood Advances|June 23, 2022
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trialVincent Camus, Aurélien Belot, Lucie Oberic, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Emerging Infectious Diseases|July 22, 2015
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic MalignanciesSuzanne Tavitian, Jean-Marie Peron, Françoise Huguet, et al.
American Journal of Hematology|July 22, 2014
Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomasMarielle Perry, Antoine Delarche, David Ribes, et al.
American Journal of Hematology|November 24, 2017
Bendamustine plus rituximab for indolent B-cell lymphoma of renal significanceDavid Ribes, Hélène E L Hachem, Lucie Oberic, et al.
Annals of Hematology|November 27, 2025
Length of hospital stay and outcome in primary central nervous system lymphoma: a French retrospective multicentric studyRaphaël Maguet, Martin Eloit, Olivier Chinot, et al.
Journal of Clinical Medicine|February 15, 2022
Spectrum of Kidney Disorders Associated with T-Cell ImmunoclonesAlexis Piedrafita, François Vergez, Julie Belliere, et al.
Blood Cancer Journal|November 3, 2025
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trialsValentin Letailleur, Isabelle Chaillol, Fanny Cherblanc, et al.
British Journal of Haematology|April 4, 2018
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA studyBenedicte Deau, Sandy Amorim, Aurore Perrot, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 12, 2024
MYC Rearrangement Prediction From LYSA Whole Slide Images in Large B-Cell Lymphoma: A Multicentric Validation of Self-supervised Deep Learning ModelsCharlotte Syrykh, Valentina Di Proietto, Eliott Brion, et al.
Oncoimmunology|December 20, 2016
Impaired functional responses in follicular lymphoma CD8<sup>+</sup>TIM-3<sup>+</sup> T lymphocytes following TCR engagementPauline Gravelle, Catherine Do, Camille Franchet, et al.
Blood Advances|June 23, 2022
Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trialVincent Camus, Aurélien Belot, Lucie Oberic, et al.
Pageof 7